Drug-free holiday in patients with rheumatoid arthritis: A qualitative study to explore patients' opinion

Clinical Rheumatology

Volumn 33, Issue 8, 2014, Pages 1155-1159

  Markusse, I M ^a   Akdemir, G ^a   Huizinga, T W J ^a   Allaart, C F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Discontinuation; Patient perspective; Rheumatoid arthritis; Tapering; Treatment

Indexed keywords

ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; PERCEPTION; QUALITATIVE RESEARCH; REMISSION; TREATMENT WITHDRAWAL;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCEPTION; QUALITATIVE RESEARCH; REMISSION INDUCTION; WITHHOLDING TREATMENT;

EID: 84904430764     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2500-y     Document Type: Article

References (15)

1. Tanaka Y, Takeuchi T, Mimori T et al (2010) Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis 69(7):1286-1291
2. Nawata M, Saito K, Nakayamada S, Tanaka Y (2008) Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission. Mod Rheumatol 18(5):460-464
3. ten Wolde S, Breedveld FC, Hermans J et al (1996) Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet 347(8998):347-352 (Pubitemid 26046101)
4. van den Broek M, Klarenbeek NB, Dirven L et al (2011) Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Ann Rheum Dis 70(8):1389-1394
5. van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK et al (2009) Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recentonset rheumatoid arthritis. Ann Rheum Dis 68(6):914-921
6. Klarenbeek NB, van der Kooij SM, Guler-Yuksel M et al (2011) Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis 70(2):315-319
7. Crow R, Gage H, Hampson S, Hart J, Kimber A, Thomas H (1999) The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technol Assess 3(3):1-96
8. Kvale S (1996) Interviews: an introduction to qualitative research interviewing. Sage, California, USA
9. Jones K (2002) The turn to a narrative knowing of persons: one method explored. Nursing Times Research 8:60-71
10. Francis JJ, JohnstonM, Robertson C et al (2010)What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health 25(10):1229-1245
11. Suter LG, Fraenkel L, Holmboe ES (2006) What factors account for referral delays for patients with suspected rheumatoid arthritis? Arthritis Rheum 55(2):300-305
12. Stamm TA, Cieza A, Coenen M et al (2005) Validating the International Classification of Functioning, Disability and Health Comprehensive Core Set for rheumatoid arthritis from the patient perspective: a qualitative study. Arthritis Rheum 53(3):431-439 (Pubitemid 40799884)
13. Detert J, Bastian H, Listing J et al (2013) Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versusmethotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study. Ann Rheum Dis 72(6):844-850
14. Wolfe F, Michaud K (2007) Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices. Arthritis Rheum 56(7):2135-2142 (Pubitemid 47173560)
15. Mugunthan K, McGuire T, Glasziou P (2011) Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Br J Gen Pract 61(590):e573-e578